Reckitt Benckiser Group PLC (RB.L)
23 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|75||2003||Non-Executive Independent Chairman of the Board|
|2011||Chief Executive Officer, Executive Director|
|59||2013||Chief Financial Officer, Executive Director|
|2011||Executive Vice President - ENA|
|2009||Executive Vice President - Supply|
- GSK pulls out of $20 billion race for Pfizer consumer assets |
- GSK pulls out of £14.2 billion race for Pfizer consumer assets |
- UPDATE 2-European shares fall further as mounting trade fears hit cyclicals
- UPDATE 3-GSK pulls out of $20 bln race for Pfizer consumer assets
- UPDATE 1-GSK pulls out of $20 bln race for Pfizer assets
- Are these the only three stocks in the FTSE 100 worth buying?
- Are these two FTSE 100 favourites massively over-priced?
- 2 top recession-proof stocks to play it safe
- Why I’m waiting for a pullback on these three core holdings
- 3 top shares to buy after Friday's results?
- 4 perfect stocks for 'Brexit Britain'!